INS and Hyperglycemia: The primary pathophysiological processes involved in the development of T2DM are a reduction in insulin secretion by β-cells and/or a decline in insulin sensitivity (insulin resistance), which causes the body to have high blood sugar levels (hyperglycemia) [6].